Article Sidebar

Submitted
Apr 13, 2021
Published
Apr 13, 2021
Download
PDF
Statistic
Read Counter : 218 Download : 79

Main Article Content

Abstract

Fast dissolving dosage forms have acquired great importance in pharmaceutical industry. The aim of this study was to formulate and characterize fast dissolving film containing meloxicam (MLX) for oral use. In this study,  as an approach to improve the solubility of MLX, solid dispersions (SD) of MLX were prepared by melting and solvent evaporation methods using Poloxamer 188 and Gelucire 44/14 alone as carrier and combination of both. The physicochemical characterizations were done by X-ray diffraction (XRD) and differential scanning calorimetry (DSC) for MLX-loaded SD and their corresponding physical mixtures as well as the individual components to investigate the drug polymer interaction.The solubility was enhanced 5-8 folds using the solid dispersion technique (F1, F4 and F9).All the prepared formulations showed about 65-100% MLX release after 60 min compared to a maximum of 23% release from the pure MLX sample. The obtained DSC and XRD results indicated that MLX was molecularly dispersed in the matrix of SD. Then, the promising formula (F9) that contained (15:42.5:42.5, drug: poloxamer: Gelucire, w/w) and prepared by melting was further incorporated into fast dissolving film (FDF) formulations. Films were prepared by solvent casting method using different quantity of film former HPMC E6. The prepared films were found to contain almost a uniform quantity of the drug. Film 2 (contained 400 mg polymer) showed the best property concerning drug release, fast disintegration time (46.3sec), mechanical strength and surface pH.

Keywords

Meloxicam Poloxamer Gelucire Film Oral Evaluation Solubility

Article Details

How to Cite
Fawziya W. Alhalabi, Gehan F. Balata, Nahla S. Barakat, Alaa F. Alsulami, Athba K. Al-Solbi, Bashair M Shoieb, Haifa A. Alotaibi, & Sarah A. Al-Ansari. (2021). Formulation and evaluation of fast dissolving film of meloxicam. International Journal of Research in Pharmacology & Pharmacotherapeutics, 6(1), 16-27. https://doi.org/10.61096/ijrpp.v6.iss1.2017.16-27
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Arya A, Chandra A, Sharma V, Pathak K, Fast dissolving oral films: an innovative drug delivery system and dosage form. Int JChem Tech Res. 2, 2010, 576-583.
  2. [2]. Dixit RP, Puthli SP, Oral strip technology: Overview and future potential. J Con Rel. 139, 2000, 94-97.
  3. [3]. Nishimuraa M, Matsuurab K, Tsukiokaa T, Yamashitac H, Inagakic N, Sugiyamad T, Itohb Y.In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. Int J Pharm. 368, 2009, 98–102.
  4. [4]. Yasmeen R B, Firoz S, Mouli YC, Vikram A, Mahitha B and Aruna U. Preparation and evaluation of oral fast dissolving films of citalopram hydrobromide. Int J Biopharm. 3(2), 2012, 103-106.
  5. [5]. Deepthi A, Venkateswara Reddy B, Navaneetha K. Formulation and evaluation of fast dissolving oral films of zolmitriptan. Der Pharmacia Lettre. 5(4), 2013, 145-152.
  6. [6]. Amir H. S. Buccal mucosa as a route for systemic drug delivery: A review. J Pharm Pharm Sci. 1(1), 1998, 15-30.
  7. [7]. Sandeep D J, Kalaber R N, Jadhav C M, Tekade B, Patil V R. Formulation and evaluation of fast dissolving oral film of levocetirizinedihydrochloride. . Int J Pharm Pharm Sci. 4, 2012, 0975-1491.
  8. [8]. LondheVY, Umalkar KB. Formulation, development and evaluation of fast dissolving film of Telmisartan. Indian J Pharm Sci. 74(2), 2012, 122–126.
  9. [9]. Vidyadhara S, Balakrishna T, Sasidhar R L C, ShowriBabu C H and Harika DL. Formulation and evaluation of zolmitriptan fast dissolving buccal films. Der Pharmacia Lettre. 5(4), 2013, 145-152.
  10. [10]. Bhikshapathi DVRN V, Madhuri D, Rajesham VV , Suthakaran R. Preparation and evaluation of fast dissolving oral film containing naratriptanHCl. American J Pharm Tech Research. 4(2), 2014, 800-812.
  11. [11]. Francesco C, Cupone IE, Minghetti P. Nicotine fast dissolving films made of maltodextrins: A feasibility study. AAPS PharmSci Tech. 11(4), 2010, 1511-1517.
  12. [12]. Siddiqui N, Garg G, Sharma PK. A Short review on “A novel approach in oral fast dissolving drug delivery system and their patents. AdvBiol Res. 5(6), 2011, 291-303.
  13. [13]. Cilurzo F, Cupone IE, Minghetti P, Buratti S, Gennari CGM, Montanari L. Diclofenac fast-dissolving film: suppression of bitterness by a taste- sensing system. Drug DevInd Pharm. 37, 2013, 252–259.
  14. [14]. Kundu S, Sahoo PK. Recent trends in the development of orally disintegrating tablet technology. Pharmaceutics 4, 2008, 11.
  15. [15]. Mishra R, Amin A. Formulation and characterization of rapidly dissolving films of cetirizine hydrochloride using pullulan as a film forming agent. Ind J Pharm Edu Res. 45(1), 2011, 75-76
  16. [16]. Patel DB. Comparative evaluation of different carriers to enhance solubility and dissolution of poor water soluble drug. Int J Pharm Bio Sci. 5(4), 2014, 463 – 471.
  17. [17]. Suresh B D, James L. Quick Dissolving Films: A novel approach to drug delivery. Drug Dev Technol.1, 2006, 7.
  18. [18]. Pairet M, Van Ryn J, Schierok H, Hauz A, TrummlitzeG,Engelhardt G. Differential inhibition of cyclooxygenase-1 and -2 by meloxicam ant its 4- isomer. Inflamm Res. 47(6), 1998, 270-276.
  19. [19]. Hanft G, Türck D, Scheuerer S, Sigmund R. Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations. Inflamm. Res. 50, 2001, S35–S37.
  20. [20]. Fahmy M. Ca-alginate beads loaded with meloxicam: effect of alginate chemical composition on the properties of the beads and ulcerogenicity of the drug. J Drug Del Sci Technol. 16, 2006, 183–189.
  21. [21]. Ambrusa R, Kocbeka P, Kristl J, ˇSibanca R R, Szabó-Révészb P. Investigation of preparation parameters to improve the dissolution of poorly water soluble meloxicam. Int J Pharm. 381(2), 2009, 153-159.
  22. [22]. Agarwal V, Alayoubi A, Siddiqui A, Nazzal S. Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration. Drug DevInd Pharm. 39, 2013, 1681-1689.
  23. [23]. Issa AA, Marchidan D , Cojocaru V, Anuta V. Preparation and evaluation of meloxicam solid dispersion by melting method. FARMACIA. 61, 2013, 6.
  24. [24]. Kumar SG V, Mishra DN. Preparation and evaluation of solid dispersion of meloxicam with skimmed milk. YakugakuZasshi. 126(2), 2006, 93–97.
  25. [25]. Ghareeb MMA , Hussein AA , Ahmed A, and Mohammed N. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS Pharm Sci Tech 10(4), 2009.
  26. [26]. Gurusamy S, Kumar V, Mishra DN. Preparation, Characterization, and In vitro dissolution studies of solid dispersion of meloxicam with PEG 6000. YakugakuZasshi126(8), 2006, 657-664.
  27. [27]. Baboota S, Agarwal SP. Inclusion complexation of Meloxicam with β-cyclodextrin. Indian J Pharm Sci.64, 2002, 408-411.
  28. [28]. Naidu NB, Chowdary KP, Murthy KV, Satyanarayana V, Hayman AR, Becket G. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems. J Pharm Biomed Anal. 35(1), 2004, 75–86.
  29. [29]. SainiS , Nanda A, Dhari J. Formulation, development & evaluation of oral fast dissolving anti-allergic film of levocetrizinedihydrochloride. J Pharm Sci. & Res.3(7), 2011, 1322-1325
  30. [30]. Inamdar N, Bhise K, Memon S. Solubility enhancement and development of dispersible tablet of meloxicam. Asian J Pharm 2, 2008, 128-32
  31. [31]. CavallariC ,Fini A and Ceschel G. Design of olanzapine/lutrol solid dispersions of improved stability and performances. Pharmaceutics. 5, 2013, 570-590.
  32. [32]. Dhere PM, Patwekar SL. Review on preparation and evaluation of oral disintegrating films. IJPT.3(4), 2011, 1572-1585.
  33. [33]. Shinde AJ, Garala KC, More HN. Development and characterization of transdermal therapeutics system of tramadol hydrochloride, Asian J Pharm 4, 2008, 265-269.
  34. [34]. Kunte S, Tandale P. Fast dissolving strips: A novel approach for the delivery of verapamil. J Pharm Bioallied Sci. 2(4), 2010, 325–328.
  35. [35]. Cilurzo F, Cupone IE, Minghetti P, Selmin F, Montanari L. Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm 70, 2008, 895-900.
  36. [36]. Hassan MA, Barakat NS , El-Badry M, Shehata SM. Formulation and in vitro/in vivo evaluation of naproxen mucoadhesivebuccal patches for local effect. J Drug Del Sci Tech. 21(5), 2011, 423-431.
  37. [37]. SainiS , Nanda A, Dhari J. Formulation, development & evaluation of oral fast dissolving anti-allergic film of levocetrizinedihydrochloride. J Pharm Sci Res. 3(7), 2011, 1322-1325
  38. [38]. Prabhu P, Malli R, Koland M, Vijaynarayana K, D’Souza U, Harish NM, Shastry CS. Formulation and evaluation of fast dissolving films of levocetrizinedihydrochloride. Int J Pharm Investig. 1(2), 2011, 99-104.
  39. [39]. Chien M J, Tirol G, Chien C, Schmitt R.Film forming polymers in oral films. Poster presented at the 2006 Annual Meeting and Exposition of the American Association of Pharmaceutical ScientistAAPS. 2006,1-5.
  40. [40]. Dinge A, Nagarsenker M. Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity. Pharm Sci Tech. 9(2), 2008, 349–356.
  41. [41]. Jafar M, Dehghan, MHG, ShareefA. Enhancement of dissolution and anti-inflammatory effect of meloxicam using solid dispersions. Int J Appl Pharm. 2, 2010, 22–27.
  42. [42]. Homayouni A, Sadeghi F, Nokhodchi A, Varshosaz J, Garekani HA. Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers. Iran J Basic Med Sci.17(5), 2014, 322-331
  43. [43]. Newman A, Knipp G, Zografi G. Assessing the performance of amorphous solid dispersions. J Pharm Sci.101, 2012, 1355–1377.
  44. [44]. Chaudhary H , Gauri S, Rathee P, Kumar. V. Development and optimization of fast dissolving oro-dispersible films of granisetronHCl using Box–Behnken statistical design. Bulletin of Faculty of Pharmacy, Cairo University. 51, 2013, 193–201.